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Abstract The clinical electro-oculogram (EOG) is
an electrophysiological test of the outer retina and
retinal pigment epithelium (RPE) in which changes in
the electrical potential across the RPE are recorded
during successive periods of dark and light adaptation.
This document presents the 2017 EOG Standard from
the International Society for Clinical Electrophysiol-
ogy of Vision (ISCEV: www.iscev.org). This standard
has been reorganized and updated to include an
explanation of the mechanism of the EOG, but without
substantive changes to the testing protocol from the
previous version published in 2011. It describes
methods for recording the EOG in clinical applications
and gives detailed guidance on technical requirements,
practical issues and reporting of results with the main
clinical measure (the Arden ratio) now termed the light
peak:dark trough ratio. The standard is intended to
promote consistent quality of testing and reporting
within and between clinical centers.
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Light peak:dark trough ratio
RPE Retinal pigment epithelium
TEP Transepithelial potential
This Standard is one of the series of ISCEV Standards
and Guidelines for clinical electrophysiology of vision
[1–7]. Current standards are listed on the ISCEVWeb
site [8]. This Standard supersedes previous versions of
the ISCEV Standard for clinical electro-oculography
which was first published in 1993 [1] and subsequently
revised most recently in 2011 [2]. This Standard
contains updated information on the mechanism and
reporting of the EOG and has been reorganized for
greater clarity and for consistency with other ISCEV
Standards, without substantive changes to the 2011
testing protocol.
This ISCEV Standard describes basic procedures
that allow reproducible recordings that are comparable
across laboratories. It is intended that the ISCEV
Standard EOG protocol be used widely, but not to the
exclusion of other tests or protocols that are not
covered by this Standard. Electrophysiologists are
encouraged to extend the EOG as required when
clinically relevant to maximize the diagnostic value of
the EOG and fast oscillation (FO) recordings.
Clinical and research users of the EOG are encour-
aged to use the most recent Standard, to achieve
consistency of results within and between test centers.
Reports of EOG recordings performed in this manner
should cite this 2017 Standard. When a method is used
which deviates from the Standard, the deviations
should be fully described.
The electro-oculogram
Electrophysiology of the outer retina in dark
and light
There is a difference in electrical potential between the
anterior and posterior of the eye, known as the
standing potential of the eye. The standing potential
is an indirect measure of the transepithelial potential
(TEP) of the retinal pigment epithelium (RPE). The
TEP is equal to the difference in the membrane
potential of the basolateral and the apical membranes,
which are electrically isolated through the tight
junctions of the RPE. Changes in the resistance
between the apical and basolateral membranes or
membrane potentials alter the amplitude of the TEP
and thus affect the recorded standing potential of the
eye. A change in the standing potential can be induced
by retinal adaptation to a change in ambient
illumination.
There are two clinical tests of the standing potential
of the eye. The EOG utilizes the RPE’s response to
changing illumination to assess the function of the
outer retina and RPE. The EOG is recorded during
15 min of dark adaptation followed by 15 min of light
adaptation. The FO is a different EOG procedure
performed during alternate 1-min dark and light
periods. The changes in the standing potential for the
EOG and the FO are derived from different
mechanisms.
Mechanism of the EOG
During the 15-min period of dark adaptation, there is a
fall in the recorded standing potential typically
reaching a minimum at 10–15 min, and this is referred
to as the dark trough (DT). Following light onset, there
is an increase in the TEP of the RPE producing the
light-rise of the EOG. The mechanism initiating the
light-rise is unknown, but it requires a normally
functioning interface between the rod photoreceptors
and RPE. The light-rise is ultimately the result of an
increase in intracellular free calcium, which is
released from the endoplasmic reticulum (ER), regu-
lated by an interaction between ER bestrophin and
L-type calcium channels associated with the basolat-
eral membrane. Intracellular calcium gates the open-
ing of a basolateral calcium-dependent chloride
channel. Increased chloride conductance depolarizes
the basolateral membrane which increases the TEP,
recorded as an increase in the standing potential of the
eye. The light-rise normally reaches a maximum at
7–12 min after light onset and is known as the light
peak (LP). The LP is the first of several peaks (the
damped oscillation) which become progressively
smaller for up to 90 min during continued light
exposure.
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The clinical EOG provides an indirect measure of
the minimum amplitude of the standing potential in
the dark (at the DT) and then again at its maximum
amplitude in the light (at the LP). This is expressed as
the EOG light peak-to-dark trough ratio (LP:DT ratio).
ISCEV recommends the term LP:DT ratio when
reporting this result.
Mechanism of the FO
The FO is an optional additional test that has a
different mechanism to the clinical EOG owing to the
shorter dark and light intervals used. At light onset,
there is a fall in potassium in the sub-retinal space that
causes a strong outward hyperpolarizing potassium
current across the RPE’s apical membrane and is
reflected in the c-wave of the electroretinogram
(ERG). The fall in sub-retinal potassium also reduces
the transport of chloride ions into the RPE. The
reduction in chloride ions causes the basolateral
membrane to hyperpolarize and lowers the TEP
generating the trough of the FO 35–45 s after light
onset. The TEP returns to normal, as ionic homeostasis
is restored and a peak is recorded during the subse-
quent dark period after a further 35–45 s. The
alternation between dark and light at 1-min intervals
establishes a continuous oscillation that is dependent
on changes in ionic permeability at the apical and
basal membranes and the electrical coupling between
these membranes by tight junctions.
Diseases affecting the light response of the EOG
The LP:DT ratio of the EOG is affected in some diffuse
disorders of the RPE and disorders of the photoreceptor
layer of the retina including acquired retinopathies and
retinal dystrophies characterized by rod dysfunction or
chorio-retinal atrophy. Inmost of these disorders, EOG
abnormalities are proportional to the severity of rod-
mediated ERG abnormalities and are not of diagnostic
importance. Notable exceptions include disorders of
the bestrophin gene (BEST1). These include Best
vitelliform macular dystrophy (Best disease), autoso-
mal recessive bestrophinopathy (ARB) and autosomal
dominant vitreoretinochoroidopathy (ADVIRC). In
Best disease standard, full-field ERGs are usually
normal and the LP:DT ratio of the EOG abnormal. An
abnormal EOG may distinguish Best disease from
other autosomal dominant retinal disorders with sim-
ilar fundus features including some cases of adult
vitelliform macular dystrophy and pattern dystrophy.
In ARB and ADVIRC, the ERG is often abnormal but
the EOG is severely or disproportionately abnormal.
An abnormal EOG, not explained by ERG reduction,
may also be associated with some toxic retinopathies.
Principles of the clinical EOG measurement
The standing potential of the eye may be assessed
using skin electrodes placed near the outer and inner
canthi of each eye to record successive horizontal
saccadic eye movements. The patient tracks alternat-
ing lights separated by a fixed angle, to enable constant
eye movement excursions which are recorded as a
series of positive and negative deflections that coin-
cide with ocular rotation. The magnitude of the eye
movement potential (at a fixed angle) is proportional




Skin electrodes such as sintered silver–silver chloride,
standard silver–silver chloride or gold cup electrodes
are recommended for recording the EOG. The skin
should be prepared by cleaning, and a suitable paste or
gel used to ensure good, stable electrical connection.
The electrode–skin contact impedances should be
below 5 kX as measured between 20 and 40 Hz.
Stimulator
Full-field (ganzfeld) stimulation must be used to
provide uniform luminance over the entire visual field
of the patient. This is usually achieved using a dome or
integrating sphere. It is incumbent on manufacturers
and users to verify that stimulation meets the full-field
requirement of this Standard and provides a comfort-
able head/chin rest for the patient. Two red fixation
lights located 15 left and right of center should be
bright enough to be just visible to the patient during
the dark and light phases of the recordings.
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Light and dark
The adapting dark phase should take place in total
darkness, with the fixation lights dimmed to the
minimum necessary to enable fixation for the patient.
The adapting light phase requires a white light with
a luminance of 100 photopic cd m-2 measured at the
position of the eye. To account for minor variability in
equipment and calibration, the acceptable range
within the Standard for the light adapting background
is 90–110 photopic cd m-2. Calibration of the
ganzfeld stimulator should be carried out periodically.
Modest room lighting may be turned on during the
light phase providing the ambient luminance is less
than that in the ganzfeld.
Note that adapting light sources of different types,
such as tungsten, halogen, LED and fluorescent bulbs,
have different spectral characteristics and the color
may change with brightness. This makes the definition
of standard lighting inherently imprecise, although for
practical purposes ‘‘white’’ light of the correct lumi-
nance will give similar results.
Amplification
Amplifiers should have a band pass of either DC to 30
or 0.1–30 Hz to make recordings of saccadic eye
movements appear as square waves (Fig. 1). For a 30
saccade, the typical EOG amplitude is between 250
and 1000 lV with an essential frequency content of
0–30 Hz. To avoid a loss of information, digitizers
should sample the saccades at a rate of 1 kHz or higher
in each channel. In theory, the ideal recording
technique is DC amplification but this is generally
impractical because of baseline drift. Thus, we
recommend AC coupling with a 0.1 Hz high-pass
and 30 Hz low-pass filter. If a higher-frequency filter
is used (e.g., 0.5 Hz), it will distort the square waves,
making identification of overshoot and stepped sac-
cades difficult.
Manufacturers should allow the examiner to have
access to all of the raw data for each 10-s recording
epoch so that the examiner is able to visually inspect
the individual saccadic records to enable accurate
cursor placement around any artifacts to measure the
standing potential as shown in Fig. 2.
The operator should be able to visually inspect
saccadic recordings as they are performed to monitor
for artifacts including those caused by blinks, incon-
sistent eye movements, patient compliance problems,
poor electrode contact or amplifier saturation. Prompt
detection allows artifacts to be minimized or elimi-
nated, e.g., by encouragement of the patient, re-
application of recording electrodes or by making
necessary adjustments to the amplifier gain.
Preparation of the patient
Pupils
The pupils should be dilated before testing and their
size or diameter recorded. If full pupil dilation is
impossible or undesirable, an attempt should be made
to increase the adapting luminance so that an equiv-
alent retinal illumination is approximated. The amount
of light passing through the pupil, when measured in
Trolands, is the product of luminance (in cd m-2) and
pupil area (in mm2). For example, to produce the same
effect upon the retina, twice as much luminance is
required with a 5-mm diameter pupil (roughly
20 mm2) than with a 7-mm diameter pupil (roughly
40 mm2). The report should describe any deviations
from the Standard.
Electrode placement
After suitable skin preparation, recording electrodes
should be placed close to the canthi of each eye as in
Fig. 3. The electrodes from each eye are connected to
separate channels of a differential amplifier. A sepa-
rate electrode should be attached and connected to the
ground. Convenient and commonly used ground
electrode positions include the forehead, vertex,
mastoid and earlobe. The impedance between any
pair of electrodes should not exceed 5 kX. The
electrodes, amplifier and impedance meter must be
approved for medical use.
Pre-exposure to light
The patient should be in stable indoor lighting for at
least 30 min before the test. Indirect ophthalmoscopy,
fundus autofluorescence, fundus photography and
other strong illumination changes must be avoided
during this period. As near as practical, the pretest
light exposure should be the same for all patients.
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Instructions to the patient
The procedure should be explained to the patient,
noting that head position must not change, as this is
one common source of artifact and that the eyes should
only move left and right. Patients should be instructed
not to anticipate the onset of the alternation of the
fixation lights but to move their eyes only when the
lights change. Practice the procedure with the record-
ing system prior to dark adaptation, to familiarize the
patient with the task and to check on the stability and

























Fig. 1 Upper trace shows filtering with 0.1–30 Hz, lower trace with post hoc DC restoration by digital integration, rendering it similar
to direct DC recording. DC recording (or restoration) makes it easier to perform the plateau measurements
Fig. 2 Examples of 10-s
saccadic records with a blink
artifact at approximately
4000 ms. Arrow a indicates
an initial undershoot and
arrow b an overshoot of the
fixation target visible by the
step in the plateau of the
EOG recording (upper
trace). The lower trace
shows the manual placing of
markers at the peak and
trough of the EOG recording
as the eye performs
horizontal saccades for 10 s
at 1-s intervals




Fixation lights should alternate once per second, for 10 s
out of every minute. The EOG potentials are recorded
during each of these 10-s periods. There should be a
warning, verbal or automatic, of the impending start of
each recordingperiod toensure readinessof thepatient and
operator.Auditory cues during the recordingsmay be used
and can be helpful in patients with restricted visual fields.
Dark phase
For the dark phase, total darkness should be main-
tained for 15 min, except for the dim fixation lights.
EOG recordings should be made once a minute for
10 s, as specified above. The operator should have a
concurrent view of the recordings to check for patient
compliance and for errors such as noise or overshoot.
Light phase
For the light phase, a ganzfeld background light of 100
photopic cd m-2 should be turned on to initiate the
light phase response and should remain on for the
duration of the light phase. However, the luminance
can be increased gradually over a short period (e.g.,
20 s) to minimize patient discomfort. Longer ramps
(e.g., lasting minutes) will alter the responses. Con-
tinue the recording for 10 s out of every minute (as
above) for at least 15 min to register the presence or
absence of the LP. If the LP can be clearly identified
during the recordings, then the test may be stopped
before 15 min. It may be necessary to extend the light
phase to fully characterize abnormal responses, but a
delay in the LP should be reported. The patient should
remain positioned in the headrest of the stimulator
throughout the procedure, with eyes open to maintain
retinal illumination.
Patient compliance
Patients will have difficulty performing saccadic eye
movements if they cannot fixate reliably because of
poor central vision, diplopia or ocular motility prob-
lems (including nystagmus). Patients with diplopia
may be advised to look between the pair of images, or
one eye can be patched if the suspected retinal disorder
is binocular. Patients who are very young or those with
Fig. 3 Recording electrode positions located near the inner and outer canthi of each eye. As the eyes perform horizontal saccades: left
(a) then right (b), the amplitude of the standing potential is recorded across the active electrodes
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a physical or learning disability may not be able to
perform the EOG. In young children with suspected
Best disease, it may be useful to test their parents,
since a carrier of Best disease will have an abnormal
light-rise, irrespective of whether the fundus is
normal.
Patient compliance can vary due to fatigue or
inattention. Common problems include gradual move-
ment of the head back from the stimulator, head
turning, irregular eye movements during the recording
or eye closure during the light phase can be minimized
by having a real-time view of the patient’s eyes via an
infrared camera. In most cases, gentle coaching and




The EOG amplitudes should be measured in micro-
volts (lV) either manually or by a computer algorithm
after visual inspection. Care must be taken to avoid
measuring the effects of overshoot (see Fig. 2) or
irregular (artifactual) saccades. The average of the
amplitudes within each 10-s recording epoch should
be measured, excluding outliers, artifacts or responses
consistent with poor eye movement accuracy. If a
computer algorithm is used, it is important to ensure
that the values obtained represent true EOG ampli-
tudes and not artifactual records or outliers. Common
causes of unreliability are overshoot of the fixation
lights, stepped rather than smooth saccades, missing
saccades, inverse saccades (eyes going in the opposite
way to the fixation lights), and eccentric fixation in
which the saccade length switches between two or
more values.
Dark trough and light peak: smoothing
The average EOG amplitude calculated from each
10-s epoch should be plotted. However, there is
always ‘‘noise’’ in physiological recordings, and the
goal of the EOG measurement is to record the
underlying DT and LP, rather than the lowest or
highest single values. Thus, the first critical step is that
the underlying physiologic curve be recognized and
drawn, in order to derive reliable DT and LP
amplitudes. This can be achieved by various methods
including visual inspection, by use of a flexible spline
rule, computer-based curve fitting algorithms or
weighted averages of the EOG amplitudes.
Figure 4 shows raw data plotted and the subsequent
smoothing of the data points using, in this case, the
weighted mean of the recorded EOG amplitudes at
each time point. It is helpful if uncertain or artifactual
values can be identified and marked at the time of
recording, so that they can be ignored later when
smoothing and curve fitting.
Light peak-to-dark trough ratio calculation
The LP:DT ratio of the EOG is computed by dividing
the smoothed LP by the DT amplitudes. It is important
to note that a normal LP:DT ratio does not imply a
normal DT and this amplitude should be reported as a
measure of the standing potential.
Reporting
Clinical reports should state the EOG LP:DT ratio, the
DT amplitude (in microvolts) and the time from the
start of the light phase to the LP (if present). The type
of adapting light source and pupil size should also be
reported. The report should also describe any difficul-
ties encountered during testing that may affect confi-
dence in the results, such as patient compliance or
inconsistent eye movements.
Normative data
Each center must establish its own set of normative
values for the EOG and FO. The median value (not the
mean) should be used to define reference values and
the actual values on either side of the median that
bracket 90 percent of the reference ranges (5th–95th
centile) should be determined by direct tabulation of
the reported results. The normal LP:DT ratio is
typically between 1.7 and 4.3 with a LP time ranging
from 7 to 12 min.
Interaction between eyes
The EOG potentials from one eye can contaminate the
response from the other. Themagnitude of this effect is
approximately 15% with electrodes placed on each
side of the nose close to the inner canthi. It rises to
about 40% if the electrodes come close together and
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touch, becoming equivalent to a common central
electrode on the bridge of the nose. This interaction can
givemisleading results if an eye is electrically inactive,
e.g., in total retinal detachment or absent. This is
because the defective eye will appear to have the same
LP:DT ratio as the fellow eye, but with a much smaller
standing potential (DT amplitude). If the eyes have
similar standing potentials but a different LP:DT ratio,
then themeasured ratio from the better eye is enhanced
at the expense of that from the weaker eye.
Deviation from the Standard
This Standard represents a basic and core procedure
for the assessment of generalized function of the RPE/
photoreceptor interface. If a center chooses techniques
that vary from the Standard, such as differences in the
luminance level for the adapting light or in the
duration of the dark or light adapting intervals, it is
critical to cite this document and specify any devia-
tions. The standing potential of the EOG can also be
used to monitor eye movements in studies unrelated to
retinal and RPE pathophysiology.
Fast oscillation
The FO has the opposite polarity to the EOG. Light
causes a decrease in the standing potential, while in
darkness there is an increase in the standing potential.
Fig. 4 Upper figure shows
the raw standing potential
values for an EOG with
15 min of dark (black
circles) and 15 min of light
(white circles). Smoothing
of the data helps to define
the DT and LP amplitudes
from which to calculate the
light peak:dark trough ratio
(lower figure). Computer
algorithms or fitting with a
spline rule may also be
utilized
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The FO is recorded using the same technical
specifications as the EOG (amplifier, electrode place-
ment, fixation targets, background luminance and 1/s
saccades). However, the saccades and the recording
should be continuous for the duration of the test. Light
and dark intervals are alternated at 60 or 75-s intervals
to induce the FO, which has a near sinusoidal
appearance (Fig. 5). The total number of light–dark
intervals should be at least 4. Pre-adaptation does not
affect the FO, so this test can be performed either
independently or before the EOG.
Figure 5 shows a FO recording formed by dark
and light intervals. The FO amplitude can be
calculated from the average of the peak-to-trough
ratios from each of the dark–light cycles. The time
to the peak or trough should be calculated from the
time of light offset or onset, respectively, and
averaged for the number of light–dark cycles in the
recording.
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